Reducing the Risk of Relapse in Patients with Relapsing Forms of Multiple Sclerosis

Reducing the Risk of Relapse in Patients with Relapsing Forms of Multiple Sclerosis is organized by AcademicCME.

Start Date: 11-05-2019
Expires: 11-04-2020

Accreditation:
AcademicCME designates this live material for a maximum of 1.0 AMA PRA Category 1 CreditTM.

Description:
This CME program will highlight recent advances in the treatment and management of multiple sclerosis (MS), with a focus on best practices for reducing risk in patients with relapsing forms of MS. The expert faculty will analyze current guidelines and recommendations, highlighting the definitions of MS activity, progression, and worsening. Various emerged and emerging agents for the treatment of multiple sclerosis will be reviewed, and clinical relevance debated. Strategies for individualizing therapy and important clinical considerations for MS treatment and management will be reviewed. Upon completion of this CME program, learners will be better equipped to implement effective, team-based care for multiple sclerosis patients in clinical practice.

Objectives:
• Understand the complexity of disease course, treatment sequencing, and remyelination to better treat relapsing forms of multiple sclerosis.
• Examine the most recent advances in therapeutics for the treatment of relapsing forms of MS.
• Apply data-driven evidence into patient-focused treatment strategies to delay disease progression and reduce relapses in patients.

Additional details will be posted as soon as information is available.